Printer Friendly

PHARMACEUTICAL RESOURCES EXPECTS TO EXPAND DISTRIBUTION ARRANGEMENTS

 SPRING VALLEY, N.Y., May 3 /PRNewswire/ -- Pharmaceutical Resources, Inc. (NYSE/PSE: PRX), announced today that it expects its distribution of generic drugs to be expanded in the near future to include additional drugs.
 Kenneth I. Sawyer, president and CEO of Pharmaceutical Resources, said that the company has reached an agreement in principle with The Generics Group B.V., an international pharmaceutical company, under which a subsidiary of Pharmaceutical Resources would be appointed as the exclusive United States distributor of at least five generic drugs to be manufactured by Generics Group affiliates. Applications for approval of the manufacture of the initial five drugs are currently pending at the U.S. Food and Drug Administration. The identity of the drugs involved will not be announced until FDA approval is secured. However, Mr. Sawyer stated that three of them are not yet off patent. This arrangement expands Pharmaceutical Resources' existing distribution arrangements with a Generics Group affiliate.
 Mr. Sawyer stated, "We are very excited about these future additions to our product line. We take pride that our performance thus far under the existing distribution agreement has given The Generics Group the confidence evidenced by this new agreement."
 Pharmaceutical Resources, Inc., through its subsidiaries, is a manufacturer and marketer of prescription and over-the-counter generic drugs.
 -0- 5/3/93
 /CONTACT: Kenneth I. Sawyer of Pharmaceutical Resources, Inc., 914-425-7100/
 (PRX)


CO: Pharmaceutical Resources, Inc. ST: New York IN: MTC SU:

LR-WB -- NY081 -- 3919 05/03/93 15:31 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 3, 1993
Words:245
Previous Article:CV REIT SIGNS $10 MILLION SECURED BANK LOAN COMMITMENT; COMPANY TO OFFER TRANSFERABLE STOCK SUBSCRIPTION RIGHTS
Next Article:KIRBY CORPORATION ANNOUNCES PROPOSED CALL FOR REDEMPTION OF CONVERTIBLE SUBORDINATED DEBENTURES
Topics:


Related Articles
PHARMACEUTICAL RESOURCES, INC. ACQUIRES EXCLUSIVE OPTION ON PRODUCT FOR TREATMENT OF HERPES LESIONS
PHARMACEUTICAL RESOURCES, INC. ANNOUNCES EXCLUSIVE U.S. LICENSING AGREEMENT FOR THE DISTRIBUTION OF GENERIC TRANSDERMAL PRODUCTS
McKESSON EXPANDS DISTRIBUTION FACILITIES IN MEMPHIS AND SOUTHERN CALIFORNIA
PHARMACEUTICAL RESOURCES EXPANDS INVESTMENT IN TRANSDERMAL PHARMACEUTICAL COMPANY
CAREMARK AND BLUE CROSS OF IDAHO FORMING NEW PRESCRIPTION BENEFIT MANAGEMENT COMPANY
PHARMACEUTICAL RESOURCES, INC. LAUNCHES THREE PRODUCTS (AMILORIDE HCI, GLIPIZIDE, AND CIMETIDINE)
Novartis Announces Future United States Health Care Manufacturing and Distribution System
AMRAD ICT & Glaxo Wellcome Collaborate to Treat Hepatitis B.
Pharmaceutical Resources Announces The Sale of Merck KGaA's Stockholdings.
LAM Pharmaceutical Expands Distribution Arrangements for Latin America.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters